The reserach group has two main areas of research, drug therapy safety and the identification and characterisation of risk markers and risk factors for cardiovascular events, the progression of kidney disease and overall mortality.
In the area of drug therapy safety, one focus of the work is on the development of methods to improve the detection and prevention of medication errors and adverse drug events/side effects. This includes pharmacoepidemiological studies in the fields of nephrology, geriatrics, oncology and emergency medicine as well as studies to improve the quality of drug information and warnings in SMPCs and software-based medical products. An increasing methodological focus is on the development, utilisation and evaluation of IT and algorithms/AI to improve drug therapy safety.
Translated with DeepL.com (free version)
Krankenhausstraße 9
91054 Erlangen